275 related articles for article (PubMed ID: 16242803)
1. Engineering chromosomes for delivery of therapeutic genes.
Irvine DV; Shaw ML; Choo KH; Saffery R
Trends Biotechnol; 2005 Dec; 23(12):575-83. PubMed ID: 16242803
[TBL] [Abstract][Full Text] [Related]
2. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
3. The use of chromosome-based vectors for animal transgenesis.
Kuroiwa Y; Yoshida H; Ohshima T; Shinohara T; Ohguma A; Kazuki Y; Oshimura M; Ishida I; Tomizuka K
Gene Ther; 2002 Jun; 9(11):708-12. PubMed ID: 12032693
[TBL] [Abstract][Full Text] [Related]
4. Construction of neocentromere-based human minichromosomes for gene delivery and centromere studies.
Wong LH; Saffery R; Choo KH
Gene Ther; 2002 Jun; 9(11):724-6. PubMed ID: 12032696
[TBL] [Abstract][Full Text] [Related]
5. Artificial and engineered chromosomes: non-integrating vectors for gene therapy.
Basu J; Willard HF
Trends Mol Med; 2005 May; 11(5):251-8. PubMed ID: 15882613
[TBL] [Abstract][Full Text] [Related]
6. Current status of polymeric gene delivery systems.
Park TG; Jeong JH; Kim SW
Adv Drug Deliv Rev; 2006 Jul; 58(4):467-86. PubMed ID: 16781003
[TBL] [Abstract][Full Text] [Related]
7. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
Douglas KL
Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery.
Dobson J
Gene Ther; 2006 Feb; 13(4):283-7. PubMed ID: 16462855
[TBL] [Abstract][Full Text] [Related]
9. Non-viral and viral vectors for gene therapy.
Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
[TBL] [Abstract][Full Text] [Related]
10. Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.
Papapetrou EP; Zoumbos NC; Athanassiadou A
Gene Ther; 2005 Oct; 12 Suppl 1():S118-30. PubMed ID: 16231044
[TBL] [Abstract][Full Text] [Related]
11. Targeted gene delivery to the lung.
Aneja MK; Geiger JP; Himmel A; Rudolph C
Expert Opin Drug Deliv; 2009 Jun; 6(6):567-83. PubMed ID: 19450167
[TBL] [Abstract][Full Text] [Related]
12. Non-viral vectors for cancer therapy.
Kaneda Y; Tabata Y
Cancer Sci; 2006 May; 97(5):348-54. PubMed ID: 16630130
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of naked DNA: gene transfer to skeletal muscle.
Liu F; Liang KW; Huang L
Mol Interv; 2001 Aug; 1(3):168-72. PubMed ID: 14993350
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular molecular genetics and gene therapy. Introduction to the terminology and technique].
Eppenberger HM
Schweiz Med Wochenschr; 1996 Oct; 126(41):1716-20. PubMed ID: 8966504
[TBL] [Abstract][Full Text] [Related]
15. Establishment of medakafish as a model for stem cell-based gene therapy: efficient gene delivery and potential chromosomal integration by baculoviral vectors.
Yan Y; Du J; Chen T; Yi M; Li M; Wang S; Li CM; Hong Y
Exp Cell Res; 2009 Aug; 315(13):2322-31. PubMed ID: 19406120
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
17. Targeting the heart with gene therapy-optimized gene delivery methods.
Müller OJ; Katus HA; Bekeredjian R
Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076
[TBL] [Abstract][Full Text] [Related]
18. Bioreducible polymers for efficient gene and siRNA delivery.
Jere D; Arote R; Jiang HL; Kim YK; Cho MH; Cho CS
Biomed Mater; 2009 Apr; 4(2):025020. PubMed ID: 19349651
[TBL] [Abstract][Full Text] [Related]
19. An infectious transfer and expression system for genomic DNA loci in human and mouse cells.
Wade-Martins R; Smith ER; Tyminski E; Chiocca EA; Saeki Y
Nat Biotechnol; 2001 Nov; 19(11):1067-70. PubMed ID: 11689853
[TBL] [Abstract][Full Text] [Related]
20. Human artificial chromosomes: potential applications and clinical considerations.
Basu J; Willard HF
Pediatr Clin North Am; 2006 Oct; 53(5):843-53, viii. PubMed ID: 17027613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
